with other countries' systems, and we'll be doing that a lot, too, in the future.
Part 11, just quickly. This was an area, of course, of a lot of concern to industry and we have spent a lot of effort up front in focusing on this to be able to clarify the scope of FDA's electronic recordkeeping requirements, to provide for enforcement discretion in the areas where interpretation is unclear. We withdrew the draft guidance on the 4th of February. What we hope to do, in order to get more information out to industry and others who have to implement part 11, is we hope to have a webcast where we can go out and provide information probably sometime in June or July.
And lastly, which of course will take a little bit longer time, is we're planning to amend 21 C.F.R., part 11, the rule and the preamble. So these are things in part 11 that we're focused on now.
Dispute resolution. One of the things we've heard time and time again from industry is the need to have some type of dispute resolution process where scientific and technical questions come up when we're doing inspections, that there is a route to come into the